Latest Research And Treatment of Coronavirus (Covid-19)

Latest Research And Treatment of Coronavirus (Covid-19)

Coronavirus (COVID-19) has spread all over the world during the last few months and millions of people have been infected by a coronavirus (COVID-19). Therefore, scientists all around the world are trying to discover an effective treatment of Coronavirus (COVID-19). Unfortunately, there is no 100% effective medicine, remedy, or vaccine which is recommended for treatment or prevention of COVID-19.

At present, treatment to the patient of coronavirus (COVID-19) is provided through clinical management. Which includes infection prevention, control measures, and supportive care including supplementary oxygen. And mechanical ventilators are also used when needed.

Many drugs are under trial and are being studied and tested in several clinical laboratories all across the globe. Some of them are approved for other indications of coronavirus (COVID-19). The purpose of this article is to provide information on some of the approved drugs such as chloroquine, hydroxychloroquine, and redeliver which are currently in use in the United States.


Remdesivir was originally tested for the treatment of Ebola, but it was not effective in the treatment of Ebola. Now redeliver is being repurposed for treatment of coronavirus (COVID-19).

It is proven effective for inhibiting the growth of Severe and Acute Respiratory Syndrome (SARS) and other similar viruses. Now it is under trial as an intravenous injection with broad antiviral activity against betacoronavirus.

The Food and Drug Administration has currently approved the use of redelivering for compassionate use, meaning only patients with severe COVID-19 disease can be approved for treatment.

Five clinical trials in China and the U.S. are currently evaluating whether redeliver can reduce complications or shorten the disease course in COVID-19 patients, the medical news site STAT reported.

An infectious disease specialist, George Thompson treated an early, severe case of COVID-19, see Science magazine he says that the patient got better after getting the drug, about 36 hours after diagnosis. Initially, the doctors were thinking that the patient will die.

However, such evidence is not sufficient to determine the effectiveness of a drug and it has yet needed to be analyzed in the labs.

Chloroquine and Hydroxy Chloroquine

Hydroxychloroquine Chloroquine and are orally administered drugs. That has been in use for the treatment of malaria and certain inflammatory conditions. Chloroquine is used for malaria treatment and chemoprophylaxis. Whereas hydroxychloroquine is used for the treatment of systemic lupus erythematosus, rheumatoid arthritis, and porphyria.

Chloroquine and hydroxychloroquine have been approved by the U.S. Food and Drug Administration for the treatment of malaria, lupus, and rheumatoid arthritis, but now research in humans suggests that these drugs could effectively treat COVID-19.

Both drugs have in-vitro activity against older types of coronavirus. A study in China shows that the treatment of COVID-19 patients with Chloroquine had clinical and virologic benefits versus a comparison group, and the Chinese have added Chloroquine as a recommended antiviral for the treatment of COVID-19.

Other Drugs (Treatment of Coronavirus)

Lopinavir-ritonavir did not show promise for the treatment of hospitalized COVID-19 patients with pneumonia in a recent clinical trial in China.  This trial was underpowered, and Lopinavir-ritonavir is under investigation in a World Health Organization study.

An antiviral drug developed in Japan by Fujifilm Toma Chemical is used to treat influenza. Last month, the drug was approved as an experimental treatment for COVID-19 infections, reported by Pharmaceutical Technology.

The drug was tested on 340 people in Wuhan. “It has a high degree of safety and is clearly effective in treatment,” Zhang Xinmin, of China’s science and technology ministry, reported by The Guardian.

The drug prevents certain viruses from replicating, by shortening the duration of the virus and improving lung conditions (clearly visible on X-rays) in tested patients.

Several other drugs are under investigation in clinical trials. And is being considered for clinical trials of prophylaxis, for COVID-19, in the United States, and around the world. Information on registered clinical trials for COVID-19 in the United States is available at icon

Coronavirus science and news

You can find all India latest jobs click here

More Information World Wide Organizations Approve Diagnostic Kits for CoVID-19